{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T20:02:53Z","timestamp":1791921773747,"version":"4.3.4"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2016,4,5]],"date-time":"2016-04-05T00:00:00Z","timestamp":1459814400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2016,4,5]],"date-time":"2016-04-05T00:00:00Z","timestamp":1459814400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Betatrophin\/angiopoietin-like protein 8 (ANGPTL8) is a liver-secreted protein recently identified as a potent stimulator of beta cell proliferation in mice. However, it is unclear how betatrophin is regulated in humans with non-alcoholic fatty liver disease (NAFLD). We investigated the role of betatrophin in mice and in humans with and without NAFLD. Serum betatrophin levels were examined by ELISA in 164 subjects, including 96 patients with NAFLD. Levels were significantly elevated in subjects with NAFLD compared with controls (1.301\u2009\u00b1\u20090.617\u2009vs. 0.900\u2009\u00b1\u20090.574\u2009\u03bcg\/L, P\u2009&lt;\u20090.001), even after stratification by diabetic or obesity status. Circulating betatrophin positively correlated with obesity or glycemic indices, liver enzyme profiles, and NAFLD status, and was confirmed by multivariate regression analyses (\u03b2\u2009=\u20090.195, P\u2009=\u20090.040). However, when including insulin resistance index in the model, the significant association between betatrophin level and NAFLD was diminished due to a mediation effect of insulin resistance on this relationship. Palmitate or tunicamycin increased betatrophin expression in HepG2 cells, while a chemical chaperone blocked its induction. Hepatic expression of betatrophin was elevated in mice with NAFLD including db\/db or ob\/ob mice and mice with a high-fat or methionine-choline deficient diet. In conclusion, circulating betatrophin was increased in mice and humans with NAFLD and its expression was induced by endoplasmic reticulum stress in hepatocytes (Clinical trial no. NCT02285218).<\/jats:p>","DOI":"10.1038\/srep24013","type":"journal-article","created":{"date-parts":[[2016,4,5]],"date-time":"2016-04-05T09:48:11Z","timestamp":1459849691000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":92,"title":["Association between betatrophin\/ANGPTL8 and non-alcoholic fatty liver disease: animal and human studies"],"prefix":"10.1038","volume":"6","author":[{"given":"Yong-ho","family":"Lee","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sang-Guk","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chan Joo","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Soo Hyun","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Young-Mi","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mi Ra","family":"Yoon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Byung Hun","family":"Jeon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jae Hyuk","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Byung-Wan","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eun Seok","family":"Kang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hyun Chul","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bong-Soo","family":"Cha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,4,5]]},"reference":[{"key":"BFsrep24013_CR1","doi-asserted-by":"publisher","first-page":"686","DOI":"10.1038\/nrgastro.2013.171","volume":"10","author":"R Loomba","year":"2013","unstructured":"Loomba, R. & Sanyal, A. J. The global NAFLD epidemic. Nat Rev Gastroenterol Hepatol 10, 686\u2013690 (2013).","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"BFsrep24013_CR2","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1016\/j.jhep.2012.12.005","volume":"58","author":"M Blachier","year":"2013","unstructured":"Blachier, M. et al. The burden of liver disease in Europe: a review of available epidemiological data. J Hepatol 58, 593\u2013608 (2013).","journal-title":"J Hepatol"},{"key":"BFsrep24013_CR3","doi-asserted-by":"publisher","first-page":"1341","DOI":"10.1056\/NEJMra0912063","volume":"363","author":"G Targher","year":"2010","unstructured":"Targher, G., Day, C. P. & Bonora, E. Risk of cardiovascular disease in patients with nonalcoholic fatty liver disease. N Engl J Med 363, 1341\u20131350 (2010).","journal-title":"N Engl J Med"},{"key":"BFsrep24013_CR4","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1210\/er.2008-0009","volume":"29","author":"N Stefan","year":"2008","unstructured":"Stefan, N., Kantartzis, K. & Haring, H. U. Causes and metabolic consequences of Fatty liver. Endocr Rev 29, 939\u2013960 (2008).","journal-title":"Endocr Rev"},{"key":"BFsrep24013_CR5","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1038\/nrgastro.2013.41","volume":"10","author":"QM Anstee","year":"2013","unstructured":"Anstee, Q. M., Targher, G. & Day, C. P. Progression of NAFLD to diabetes mellitus, cardiovascular disease or cirrhosis. Nat Rev Gastroenterol Hepatol 10, 330\u2013344 (2013).","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"BFsrep24013_CR6","doi-asserted-by":"publisher","first-page":"865","DOI":"10.1002\/hep.21327","volume":"44","author":"M Ekstedt","year":"2006","unstructured":"Ekstedt, M. et al. Long-term follow-up of patients with NAFLD and elevated liver enzymes. Hepatology 44, 865\u2013873 (2006).","journal-title":"Hepatology"},{"key":"BFsrep24013_CR7","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1002\/hep.23314","volume":"51","author":"C Soderberg","year":"2010","unstructured":"Soderberg, C. et al. Decreased survival of subjects with elevated liver function tests during a 28-year follow-up. Hepatology 51, 595\u2013602 (2010).","journal-title":"Hepatology"},{"key":"BFsrep24013_CR8","doi-asserted-by":"publisher","first-page":"792","DOI":"10.1002\/hep.22429","volume":"48","author":"AL Fracanzani","year":"2008","unstructured":"Fracanzani, A. L. et al. Risk of severe liver disease in nonalcoholic fatty liver disease with normal aminotransferase levels: a role for insulin resistance and diabetes. Hepatology 48, 792\u2013798 (2008).","journal-title":"Hepatology"},{"key":"BFsrep24013_CR9","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1186\/s12933-014-0133-8","volume":"13","author":"R Zhang","year":"2014","unstructured":"Zhang, R. & Abou-Samra, A. B. A dual role of lipasin (betatrophin) in lipid metabolism and glucose homeostasis: consensus and controversy. Cardiovasc Diabetol 13, 133 (2014).","journal-title":"Cardiovasc Diabetol"},{"key":"BFsrep24013_CR10","doi-asserted-by":"publisher","first-page":"16109","DOI":"10.1073\/pnas.1315292110","volume":"110","author":"Y Wang","year":"2013","unstructured":"Wang, Y. et al. Mice lacking ANGPTL8 (Betatrophin) manifest disrupted triglyceride metabolism without impaired glucose homeostasis. Proc Natl Acad Sci USA 110, 16109\u201316114 (2013).","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFsrep24013_CR11","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1038\/nbt.1644","volume":"28","author":"T Tang","year":"2010","unstructured":"Tang, T. et al. A mouse knockout library for secreted and transmembrane proteins. Nat Biotechnol 28, 749\u2013755 (2010).","journal-title":"Nat Biotechnol"},{"key":"BFsrep24013_CR12","doi-asserted-by":"publisher","first-page":"786","DOI":"10.1016\/j.bbrc.2012.07.038","volume":"424","author":"RLipasin Zhang","year":"2012","unstructured":"Zhang, R. Lipasin, a novel nutritionally-regulated liver-enriched factor that regulates serum triglyceride levels. Biochem Biophys Res Commun 424, 786\u2013792 (2012).","journal-title":"Biochem Biophys Res Commun"},{"key":"BFsrep24013_CR13","doi-asserted-by":"publisher","first-page":"E334","DOI":"10.1152\/ajpendo.00084.2012","volume":"303","author":"G Ren","year":"2012","unstructured":"Ren, G., Kim, J. Y. & Smas, C. M. Identification of RIFL, a novel adipocyte-enriched insulin target gene with a role in lipid metabolism. Am J Physiol Endocrinol Metab 303, E334\u2013351 (2012).","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"BFsrep24013_CR14","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1016\/j.cell.2013.04.008","volume":"153","author":"P Yi","year":"2013","unstructured":"Yi, P., Park, J. S. & Melton, D. A. Betatrophin: a hormone that controls pancreatic beta cell proliferation. Cell 153, 747\u2013758 (2013).","journal-title":"Cell"},{"key":"BFsrep24013_CR15","doi-asserted-by":"publisher","first-page":"1126","DOI":"10.1016\/j.bbrc.2012.12.025","volume":"430","author":"Z Fu","year":"2013","unstructured":"Fu, Z., Yao, F., Abou-Samra, A. B. & Zhang, R. Lipasin, thermoregulated in brown fat, is a novel but atypical member of the angiopoietin-like protein family. Biochem Biophys Res Commun 430, 1126\u20131131 (2013).","journal-title":"Biochem Biophys Res Commun"},{"key":"BFsrep24013_CR16","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1007\/s00125-013-3071-1","volume":"57","author":"D Espes","year":"2014","unstructured":"Espes, D., Lau, J. & Carlsson, P. O. Increased circulating levels of betatrophin in individuals with long-standing type 1 diabetes. Diabetologia 57, 50\u201353 (2014).","journal-title":"Diabetologia"},{"key":"BFsrep24013_CR17","doi-asserted-by":"publisher","first-page":"5013","DOI":"10.1038\/srep05013","volume":"4","author":"Z Fu","year":"2014","unstructured":"Fu, Z. et al. Elevated circulating lipasin\/betatrophin in human type 2 diabetes and obesity. Sci Rep 4, 5013 (2014).","journal-title":"Sci Rep"},{"key":"BFsrep24013_CR18","doi-asserted-by":"publisher","first-page":"323407","DOI":"10.1155\/2014\/323407","volume":"2014","author":"D Espes","year":"2014","unstructured":"Espes, D., Martinell, M. & Carlsson, P. O. Increased circulating betatrophin concentrations in patients with type 2 diabetes. Int J Endocrinol 2014, 323407 (2014).","journal-title":"Int J Endocrinol"},{"key":"BFsrep24013_CR19","doi-asserted-by":"publisher","first-page":"2718","DOI":"10.2337\/dc14-0602","volume":"37","author":"H Hu","year":"2014","unstructured":"Hu, H. et al. Increased circulating levels of betatrophin in newly diagnosed type 2 diabetic patients. Diabetes Care 37, 2718\u20132722 (2014).","journal-title":"Diabetes Care"},{"key":"BFsrep24013_CR20","doi-asserted-by":"publisher","first-page":"4753","DOI":"10.1210\/jc.2006-0587","volume":"91","author":"KM Utzschneider","year":"2006","unstructured":"Utzschneider, K. M. & Kahn, S. E. Review: The role of insulin resistance in nonalcoholic fatty liver disease. J Clin Endocrinol Metab 91, 4753\u20134761 (2006).","journal-title":"J Clin Endocrinol Metab"},{"key":"BFsrep24013_CR21","doi-asserted-by":"publisher","first-page":"1147","DOI":"10.1016\/j.jhep.2012.06.018","volume":"57","author":"D Imrie","year":"2012","unstructured":"Imrie, D. & Sadler, K. C. Stress management: How the unfolded protein response impacts fatty liver disease. J Hepatol 57, 1147\u20131151 (2012).","journal-title":"J Hepatol"},{"key":"BFsrep24013_CR22","doi-asserted-by":"publisher","first-page":"19751","DOI":"10.1073\/pnas.1217552109","volume":"109","author":"F Quagliarini","year":"2012","unstructured":"Quagliarini, F. et al. Atypical angiopoietin-like protein that regulates ANGPTL3. Proc Natl Acad Sci USA 109, 19751\u201319756 (2012).","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFsrep24013_CR23","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1016\/j.cell.2014.09.027","volume":"159","author":"V Gusarova","year":"2014","unstructured":"Gusarova, V. et al. ANGPTL8\/betatrophin does not control pancreatic beta cell expansion. Cell 159, 691\u2013696 (2014).","journal-title":"Cell"},{"key":"BFsrep24013_CR24","doi-asserted-by":"publisher","first-page":"20","DOI":"10.4161\/auto.26126","volume":"10","author":"YH Tseng","year":"2014","unstructured":"Tseng, Y. H. et al. Chromosome 19 open reading frame 80 is upregulated by thyroid hormone and modulates autophagy and lipid metabolism. Autophagy 10, 20\u201331 (2014).","journal-title":"Autophagy"},{"key":"BFsrep24013_CR25","doi-asserted-by":"publisher","first-page":"2331","DOI":"10.1172\/JCI2961","volume":"101","author":"JD Horton","year":"1998","unstructured":"Horton, J. D. et al. Activation of cholesterol synthesis in preference to fatty acid synthesis in liver and adipose tissue of transgenic mice overproducing sterol regulatory element-binding protein-2. J Clin Invest 101, 2331\u20132339 (1998).","journal-title":"J Clin Invest"},{"key":"BFsrep24013_CR26","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1208\/s12248-012-9429-3","volume":"15","author":"M Gao","year":"2013","unstructured":"Gao, M. & Liu, D. The liver X receptor agonist T0901317 protects mice from high fat diet-induced obesity and insulin resistance. AAPS J 15, 258\u2013266 (2013).","journal-title":"AAPS J"},{"key":"BFsrep24013_CR27","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1016\/j.tem.2012.06.003","volume":"23","author":"M Flamment","year":"2012","unstructured":"Flamment, M., Hajduch, E., Ferre, P. & Foufelle, F. New insights into ER stress-induced insulin resistance. Trends Endocrinol Metab 23, 381\u2013390 (2012).","journal-title":"Trends Endocrinol Metab"},{"key":"BFsrep24013_CR28","doi-asserted-by":"publisher","first-page":"800","DOI":"10.4254\/wjh.v6.i11.800","volume":"6","author":"HJ Yoon","year":"2014","unstructured":"Yoon, H. J. & Cha, B. S. Pathogenesis and therapeutic approaches for non-alcoholic fatty liver disease. World J Hepatol 6, 800\u2013811 (2014).","journal-title":"World J Hepatol"},{"key":"BFsrep24013_CR29","doi-asserted-by":"publisher","first-page":"2232","DOI":"10.1007\/s00125-014-3346-1","volume":"57","author":"Z Fu","year":"2014","unstructured":"Fu, Z., Abou-Samra, A. B. & Zhang, R. An explanation for recent discrepancies in levels of human circulating betatrophin. Diabetologia 57, 2232\u20132234 (2014).","journal-title":"Diabetologia"},{"key":"BFsrep24013_CR30","doi-asserted-by":"publisher","first-page":"E96","DOI":"10.1210\/jc.2014-2300","volume":"100","author":"X Chen","year":"2015","unstructured":"Chen, X. et al. Circulating betatrophin levels are increased in patients with type 2 diabetes and associated with insulin resistance. J Clin Endocrinol Metab 100, E96\u2013E100 (2015).","journal-title":"J Clin Endocrinol Metab"},{"key":"BFsrep24013_CR31","doi-asserted-by":"publisher","first-page":"E2510","DOI":"10.1210\/jc.2013-4349","volume":"99","author":"T Ebert","year":"2014","unstructured":"Ebert, T. et al. Circulating Angiopoietin-like Protein 8 Is Independently Associated With Fasting Plasma Glucose and Type 2 Diabetes Mellitus. J Clin Endocrinol Metab 99, E2510\u20132517 (2014).","journal-title":"J Clin Endocrinol Metab"},{"key":"BFsrep24013_CR32","doi-asserted-by":"publisher","first-page":"E2004","DOI":"10.1210\/jc.2014-1568","volume":"99","author":"J Gomez-Ambrosi","year":"2014","unstructured":"Gomez-Ambrosi, J. et al. Circulating betatrophin concentrations are decreased in human obesity and type 2 diabetes. J Clin Endocrinol Metab 99, E2004\u20132009 (2014).","journal-title":"J Clin Endocrinol Metab"},{"key":"BFsrep24013_CR33","doi-asserted-by":"publisher","first-page":"1204","DOI":"10.1007\/s00125-014-3208-x","volume":"57","author":"A Fenzl","year":"2014","unstructured":"Fenzl, A. et al. Circulating betatrophin correlates with atherogenic lipid profiles but not with glucose and insulin levels in insulin-resistant individuals. Diabetologia 57, 1204\u20131208 (2014).","journal-title":"Diabetologia"},{"key":"BFsrep24013_CR34","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1530\/EJE-11-0864","volume":"166","author":"JW Haukeland","year":"2012","unstructured":"Haukeland, J. W. et al. Fetuin A in nonalcoholic fatty liver disease: in vivo and in vitro studies. Eur J Endocrinol 166, 503\u2013510 (2012).","journal-title":"Eur J Endocrinol"},{"key":"BFsrep24013_CR35","doi-asserted-by":"publisher","first-page":"63","DOI":"10.4093\/dmj.2013.37.1.63","volume":"37","author":"HY Choi","year":"2013","unstructured":"Choi, H. Y. et al. Increased selenoprotein p levels in subjects with visceral obesity and nonalcoholic Fatty liver disease. Diabetes Metab J 37, 63\u201371 (2013).","journal-title":"Diabetes Metab J"},{"key":"BFsrep24013_CR36","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1053\/gast.2002.35354","volume":"123","author":"S Saadeh","year":"2002","unstructured":"Saadeh, S. et al. The utility of radiological imaging in nonalcoholic fatty liver disease. Gastroenterology 123, 745\u2013750 (2002).","journal-title":"Gastroenterology"},{"key":"BFsrep24013_CR37","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1148\/radiol.2301021176","volume":"230","author":"P Limanond","year":"2004","unstructured":"Limanond, P. et al. Macrovesicular hepatic steatosis in living related liver donors: correlation between CT and histologic findings. Radiology 230, 276\u2013280 (2004).","journal-title":"Radiology"},{"key":"BFsrep24013_CR38","doi-asserted-by":"crossref","unstructured":"American Diabetes Association. Standards of medical care in diabetes\u20132014. Diabetes Care 37 Suppl 1, S14\u201380 (2014).","DOI":"10.2337\/dc14-S014"},{"key":"BFsrep24013_CR39","doi-asserted-by":"publisher","first-page":"1723","DOI":"10.2337\/dc11-2347","volume":"35","author":"YH Lee","year":"2012","unstructured":"Lee, Y. H. et al. A simple screening score for diabetes for the Korean population: development, validation, and comparison with other scores. Diabetes Care 35, 1723\u20131730 (2012).","journal-title":"Diabetes Care"},{"key":"BFsrep24013_CR40","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1007\/BF00280883","volume":"28","author":"DR Matthews","year":"1985","unstructured":"Matthews, D. R. et al. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28, 412\u2013419 (1985).","journal-title":"Diabetologia"},{"key":"BFsrep24013_CR41","doi-asserted-by":"publisher","first-page":"1173","DOI":"10.1037\/0022-3514.51.6.1173","volume":"51","author":"RM Baron","year":"1986","unstructured":"Baron, R. M. & Kenny, D. A. The moderator-mediator variable distinction in social psychological research: conceptual, strategic, and statistical considerations. J Pers Soc Psychol 51, 1173\u20131182 (1986).","journal-title":"J Pers Soc Psychol"},{"key":"BFsrep24013_CR42","unstructured":"R Core Team R: A language and environment for statistical computing. R Foundation for Statistical Computing, Vienna, Austria. URL http:\/\/www.R-project.org\/. (2013)."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/srep24013.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/srep24013","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/srep24013.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,5]],"date-time":"2023-01-05T04:40:48Z","timestamp":1672893648000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/srep24013"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,4,5]]},"references-count":42,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2016,4,26]]}},"alternative-id":["BFsrep24013"],"URL":"https:\/\/doi.org\/10.1038\/srep24013","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,4,5]]},"assertion":[{"value":"18 August 2015","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 March 2016","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 April 2016","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing financial interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"24013"}}